Rescue Valve-in-Valve-in-Valve TAVR for Acute Transvalvular Aortic Regurgitation

Cardiovasc Revasc Med. 2020 Nov;21(11S):11-13. doi: 10.1016/j.carrev.2020.07.002. Epub 2020 Jul 6.

Abstract

Transcatheter aortic valve replacement (TAVR) is a well-established treatment option for severe symptomatic aortic stenosis (Leon et al., 2016), and recently has also been utilised for bioprosthetic surgical aortic valve (sAVR) failure (valve-in-valve TAVR (ViV-TAVR)) (Yoon et al., 2017; Nalluri et al., 2018). Data supporting ViV-TAVR are limited to observational studies but suggest similar outcomes to re-do sAVR in high risk patients (Barbanti et al., n.d.). Whilst bioprosthetic SAVR failure is well documented, TAVR failure is less well described (Barbanti et al., n.d.). Here, we describe a case of TAVR failure in a previous sAVR resulting in the need for emergent valve-in-valve-in-valve TAVR (ViViV-TAVR).

Keywords: Aortic stenosis; Transcatheter aortic valve replacement; Valve in valve.

Publication types

  • Case Reports

MeSH terms

  • Aortic Valve / surgery
  • Aortic Valve Insufficiency*
  • Aortic Valve Stenosis* / surgery
  • Heart Valve Prosthesis Implantation*
  • Heart Valve Prosthesis*
  • Humans
  • Risk Factors
  • Transcatheter Aortic Valve Replacement*
  • Treatment Outcome